These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15711991)

  • 41. Selective botulinum chemodenervation of the scalene muscles for treatment of neurogenic thoracic outlet syndrome.
    Jordan SE; Ahn SS; Freischlag JA; Gelabert HA; Machleder HI
    Ann Vasc Surg; 2000 Jul; 14(4):365-9. PubMed ID: 10943789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidental aggravation of venous malformation after botulinum toxin type a injection for reducing benign masseteric hypertrophy.
    Choi JH; Park SW; Chung HY; Choi KY; Chang HW; Kim JH; Son D; Han K; Cho HC; Xu L; Choi TH; Kim S
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2188-92. PubMed ID: 21134051
    [No Abstract]   [Full Text] [Related]  

  • 43. A Multicenter Phase II Study Evaluating the Safety and Efficacy of Botulax in Asian Patients with Benign Masseteric Hypertrophy.
    Lee JS; Son HS; Kim BJ; Lee YW
    Plast Reconstr Surg; 2024 May; 153(5):910e-918e. PubMed ID: 37335589
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Muscle weakness after repeated injection of botulinum toxin type A evaluated according to bite force measurement of human masseter muscle.
    Kim KS; Byun YS; Kim YJ; Kim ST
    Dermatol Surg; 2009 Dec; 35(12):1902-6. PubMed ID: 19737290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lower facial contouring with botulinum toxin type A.
    Tartaro G; Rauso R; Santagata M; Santillo V; Itro A
    J Craniofac Surg; 2008 Nov; 19(6):1613-7. PubMed ID: 19098563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of botulinum toxin type A injection on lower facial contouring evaluated using a three-dimensional laser scan.
    Shim WH; Yoon SH; Park JH; Choi YC; Kim ST
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2161-6. PubMed ID: 21134047
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulinum toxin a for lower facial contouring: a prospective study.
    Yu CC; Chen PK; Chen YR
    Aesthetic Plast Surg; 2007; 31(5):445-51; discussion 452-3. PubMed ID: 17674088
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prolonging the duration of masseter muscle reduction by adjusting the masticatory movements after the treatment of masseter muscle hypertrophy with botulinum toxin type a injection.
    Wei J; Xu H; Dong J; Li Q; Dai C
    Dermatol Surg; 2015 Jan; 41 Suppl 1():S101-9. PubMed ID: 25548838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonsurgical reshaping of the lower face.
    Liew S; Dart A
    Aesthet Surg J; 2008; 28(3):251-7. PubMed ID: 19083534
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.
    Klein FH; Brenner FM; Sato MS; Robert FM; Helmer KA
    An Bras Dermatol; 2014; 89(6):878-84. PubMed ID: 25387491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The risorius muscle: anatomic considerations with reference to botulinum neurotoxin injection for masseteric hypertrophy.
    Bae JH; Choi DY; Lee JG; Seo KK; Tansatit T; Kim HJ
    Dermatol Surg; 2014 Dec; 40(12):1334-9. PubMed ID: 25393348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The medical management of masseteric hypertrophy with botulinum toxin type A.
    Moore AP; Wood GD
    Br J Oral Maxillofac Surg; 1994 Feb; 32(1):26-8. PubMed ID: 8136334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Masseter Muscle and Its Role in Facial Contouring, Aging, and Quality of Life: A Literature Review.
    Almukhtar RM; Fabi SG
    Plast Reconstr Surg; 2019 Jan; 143(1):39e-48e. PubMed ID: 30303926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [New techniques in maxillofacial surgery: local injection treatment with botulinum toxin A].
    Roser M; Cornelius CP; Topka H
    Mund Kiefer Gesichtschir; 1998 May; 2 Suppl 1():S121-4. PubMed ID: 9658837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. One-Year Relapse of Mandibular Distraction for Hemifacial Microsomia Using Masseteric Botulinum Toxin Type A Injections.
    Yin HY; Wang C; Zhang ZY; Shi L; Yin L; Liu W; Feng S; Cao YL; Tang XJ
    J Craniofac Surg; 2018 Oct; 29(7):1737-1741. PubMed ID: 29894467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and Safety of PrabotulinumtoxinA in Subjects With Benign Masseteric Hypertrophy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase 3 Trial and Open-Label Extension Study.
    Seok J; Koh YG; Hong JK; Yun SH; Kim DH; Son HS; Choi SY; Yoo KH; Lee YW; Kim BJ
    Dermatol Surg; 2024 Jun; 50(6):527-533. PubMed ID: 38518110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of botulinum toxin type A injection into human masseter muscle on stimulated parotid saliva flow rate.
    Kwon JS; Kim ST; Jeon YM; Choi JH
    Int J Oral Maxillofac Surg; 2009 Apr; 38(4):316-20. PubMed ID: 19231136
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unilateral masseter muscle hypertrophy: a case report.
    Trujillo R; Fontão FN; de Sousa SM
    Quintessence Int; 2002; 33(10):776-9. PubMed ID: 12553622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative study of the efficacy and safety of radiofrequency ablation and botulinum toxin A in treating masseteric hypertrophy.
    Huang JL; Chen G; Chen XD; Zhou BR; Luo D
    Exp Ther Med; 2014 May; 7(5):1203-1208. PubMed ID: 24940412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Obstructive parotitis secondary to an acute masseteric bend.
    Reddy R; White DR; Gillespie MB
    ORL J Otorhinolaryngol Relat Spec; 2012; 74(1):12-5. PubMed ID: 22156562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.